Search

everythinglearnresearchcommunity

for

Search:↓

2007 research improved understanding of prostate cancer risk, diagnosis, and treatment, but also showed the need for personalized treatment and further study on certain therapies' risks.

Adding hormone therapy to radiation improves survival for high-risk prostate cancer recurrence but has side effects.

Some early breast cancer patients have long-term hair loss after chemotherapy, especially older and postmenopausal women.

Melatonin may protect hair follicle cells from damage caused by a chemotherapy drug.

Chemotherapy patients don't all lose their hair due to factors like hair growth rates, age, genetics, and the type of drugs used.

Oral minoxidil can potentially increase hair growth in people suffering from Central Centrifugal Cicatricial Alopecia.

New drugs and therapies targeting specific pathways show promise in treating advanced prostate cancer.

Vijaya successfully fought stage 2A breast cancer with surgery, chemotherapy, radiotherapy, and hormone therapy, while advocating for support groups.

Topical minoxidil may help regrow hair after permanent hair loss from chemotherapy.

Some breast cancer treatments caused long-term hair loss in women, similar to a condition called alopecia areata.

Chemotherapy can cause skin issues and hair loss, and this guide explains how to manage them.

Chemotherapy significantly lowers Inhibin A levels in breast cancer patients.

The Li-Pa/Ca and Do/Ca chemotherapy regimens for serous ovarian cancer showed better short-term and long-term results than the Pa/Ca regimen.

The FDA approved a new breast cancer treatment, found flu shots may reduce heart risks, questioned the safety of fast-tracked drug approvals, showed statins don't help with certain pneumonia, and approved a new dementia imaging agent.

In 2002, various skin reactions were reported due to different drugs, including allergies, hair loss, skin lesions, and other skin conditions.

Chemotherapy can cause permanent, non-reversible hair loss similar to pattern baldness.

Cooling the scalp may prevent hair loss from chemotherapy, hair often grows back after treatment, and nail issues usually improve after stopping the drug.

5-Alpha reductase inhibitors may prevent prostate cancer but are not widely used due to concerns about trial relevance and potential risks, and more research is needed to confirm long-term benefits.

Patients with advanced breast cancer and high hormone receptor levels who had surgery for ovarian/pelvic metastases lived longer, especially if they had high estrogen receptor levels.

Triple Hormonal Blockade (ADT3) can effectively manage prostate cancer but requires careful monitoring for heart risks.

Many adult women experience unexplained excessive hair shedding, often starting before age 40.

Chemotherapy causes hair loss by damaging hair follicles and stem cells, with more research needed for prevention and treatment.

Scientists made the first metal-based compounds from a nonsteroidal antiandrogen drug, which showed potential in fighting both hormone-dependent and independent prostate cancer cells.

Gefitinib can cause skin problems, diarrhea, and nausea, but rarely causes severe lung disease or hair loss.

The conclusion suggests that prostate cancer should be classified by castration status and that new therapies targeting androgen receptor signaling show promise.

Low dose oral minoxidil helps regrow hair in permanent chemotherapy-induced alopecia.

Some drugs used to treat inflammation may cause hair loss.

Permanent hair loss after bone marrow transplant can be caused by chemotherapy or chronic graft-versus-host disease.

New chemotherapy drugs cause skin side effects, but treatments like minocycline and tetracycline can help reduce them.

The new chemotherapy combination of WP 631 and Epothilone B shows enhanced effectiveness against ovarian cancer but requires more research on its safety.